This report documents the treatment of a 41-year-old male with sickle cell disease (SCD) and repeated stuttering priapism using crizanlizumab, which alleviated the priapism but induced a significant vaso-occlusive crisis during the second infusion. Encouragingly, no subsequent vaso-occlusive crises occurred. However, the potential for infusion-related adverse events warrants close supervision. Further research is necessary to explore its full benefits on priapism management.
Keywords: acute chest syndrome; crizanlizumab; infusion‐related reactions; pain crises; priapism; vaso‐occlusive crises.
© 2024 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.